Free Trial

Mara Goldstein Analyst Performance

Analyst at Mizuho

Mara Goldstein is a stock analyst at Mizuho focused in the medical sector, covering 31 publicly traded companies. Over the past year, Mara Goldstein has issued 3 stock ratings, including and buy recommendations. While full access to Mara Goldstein's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mara Goldstein's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
247 Last 11 Years
Buy Recommendations
73.17% 180 Buy Ratings
Companies Covered
31 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy73.2%180 ratings
Hold26.0%64 ratings
Sell0.8%2 ratings

Out of 246 total stock ratings issued by Mara Goldstein at Mizuho, the majority (73.2%) have been Buy recommendations, followed by 26.0% Hold and 0.8% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
87.1% of companies on NASDAQ
27 companies
NYSE
12.9% of companies on NYSE
4 companies

Mara Goldstein, an analyst at Mizuho, currently covers 31 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
29 companies
93.5%
Consumer Discretionary
1 company
3.2%
Energy
1 company
3.2%

Mara Goldstein of Mizuho specializes in stock coverage within the Medical sector, with additional focus on Consumer Discretionary and Energy companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
19 companies
61.3%
MED - DRUGS
4 companies
12.9%
PHARMACEUTICAL PREPARATIONS
2 companies
6.5%
BIOTECHNOLOGY
2 companies
6.5%
LARGE CAP PHARMA
1 company
3.2%
MEDIA CONGLOM
1 company
3.2%
SOLAR
1 company
3.2%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
1 company
3.2%

Mara Goldstein's Ratings History at Mizuho

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
3/24/2026Lower Price Target$8.02$25.00Outperform
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
5/19/2025Lower Price Target$6.20$30.00Outperform
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
5/12/2025Lower Price Target$1.81$10.00Outperform
Verastem, Inc. stock logo
VSTM
Verastem
4/9/2025Lower Price Target$4.64$8.00Outperform